cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Curevac
30 own
10 watching
Current Price
$0
$0.25
(2.74%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
1,704.67M
52-Week High
52-Week High
19.31
52-Week Low
52-Week Low
5.63
Average Volume
Average Volume
0.09M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization1,704.67M
icon52-Week High19.31
icon52-Week Low5.63
iconAverage Volume0.09M
iconDividend Yield--
iconP/E Ratio--
What does the Curevac do?
We are a global clinical-stage biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid that has the potential to improve the lives of people. Our vision is to revolutionize medicine and open new avenues for developing therapies by enabling the body to make its own drugs. --- Our principal executive offices are located at Friedrich-Miescher-Strasse 15, 72076 Tübingen, Germany. Our telephone number at this address is +49 7071 98830. Our principal website is www.curevac.com.
Read More
News & Events about Curevac.
Accesswire
3 months ago
TÜBINGEN, GERMANY / BOSTON, MA / ACCESSWIRE / February 7, 2023 / CureVac N.V. (NASDAQ:CVAC) ("CureVac"), a global biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid ("mRNA"), announced today that it intends...
Accesswire
4 months ago
CureVac recognized as a Top 100 innovator in acknowledgment of the company's innovative strength and extensive intellectual property portfolioThe company holds one of broadest intellectual property portfolios in mRNA technologyTÜBINGEN, GERMANY and BOSTON, MA / ACCESSWIRE / January 31...
Accesswire
4 months ago
Continued technology platform validation with extended preliminary data from older adults in ongoing Phase 1 studies in COVID-19 and fluCOVID-19: monovalent modified mRNA construct CV0501 successfully boosted antibody titers against BA.1 and ancestral variants in adults age ≥65Flu...
Invezz News
4 months ago
Shares of CureVac BV (NASDAQ: CVAC) have already almost doubled year-to-date but a UBS analyst says the stock still has a lot more room to the upside. CureVac stock could gain close to 100% On Thursday, Eliana Merle turned bullish on the biopharmaceutical firm and sharply increased her price ...
Frequently Asked Questions
Frequently Asked Questions
What is Curevac share price today?
plus_minus_icon
Can Indians buy Curevac shares?
plus_minus_icon
How can I buy Curevac shares from India?
plus_minus_icon
Can Fractional shares of Curevac be purchased?
plus_minus_icon
What are the documents required to start investing in Curevac stocks?
plus_minus_icon
What is today’s traded volume of Curevac?
plus_minus_icon
What is today’s market capitalisation of Curevac?
plus_minus_icon
What is the 52-Week High and Low Range of Curevac?
plus_minus_icon
What percentage is Curevac down from its 52-Week High?
plus_minus_icon
What percentage is Curevac up from its 52-Week Low?
plus_minus_icon
Current Price
$0
$0.25
(2.74%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00